Ligand validation:4AJX

RCO: RESORCINOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AJX_RCO_J_1029	97%	65%	0.074	0.989	0.34	0.99	-	-	0	0	100%	1
4AJX_RCO_B_1030	95%	55%	0.077	0.982	0.57	1.17	-	1	0	0	100%	1
4AJX_RCO_D_1029	95%	70%	0.084	0.986	0.41	0.73	-	-	0	0	100%	1
4AJX_RCO_G_1022	94%	60%	0.089	0.988	0.78	0.77	-	-	0	0	100%	1
4AJX_RCO_L_1030	90%	66%	0.104	0.989	0.52	0.77	-	-	0	0	100%	1
4AJX_RCO_E_1022	87%	58%	0.086	0.956	0.56	1.05	-	1	0	0	100%	1
2OM0_RCO_U_704	99%	57%	0.051	0.987	1.15	0.53	1	-	0	0	100%	1
2OLY_RCO_C_504	98%	71%	0.061	0.984	0.83	0.32	-	-	0	0	100%	1
2OM1_RCO_G_1002	98%	65%	0.062	0.984	0.83	0.51	-	-	0	0	100%	1
2OMI_RCO_A_301	91%	39%	0.093	0.978	1.07	1.31	1	1	0	0	100%	1
3ZU1_RCO_D_1029	89%	33%	0.078	0.957	1.35	1.29	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.